{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-024277","form_type":"8-K","ticker":"XAIR","cik":"0001641631","company_name":"Beyond Air, Inc.","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.386394+00:00","generated_at":"2026-06-01T03:54:35.529872+00:00","sec_items":["8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Beyond Air appoints David Webster as Chief Commercial Officer effective July 8, 2024","bullets":["David Webster appointed CCO, effective July 8, 2024, with over 20 years life sciences experience.","Previously CEO of Body Vision Medical; led commercialization of Lung Vision system.","Received inducement stock option for 125,000 shares, vesting over four years starting July 8, 2024.","Company expects Webster to drive LungFit PH market share gains and strengthen commercial team."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-024277","json":"https://secwatch.observer/filing/0001493152-24-024277.json","markdown":"https://secwatch.observer/filing/0001493152-24-024277.md","text":"https://secwatch.observer/filing/0001493152-24-024277.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224024277/0001493152-24-024277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224024277/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:54:35.529872+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}